These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1780293)

  • 1. [Suppression of development of autoimmune thyroiditis during prolonged stimulation of T-cellular immunity].
    Artemova EP; Nugmanova LB
    Probl Endokrinol (Mosk); 1991; 37(5):44-7. PubMed ID: 1780293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [T-lymphocyte subpopulations in autoimmune and subacute thyroiditis treated with T-activin].
    Sakaeva NA; Balabolkin MI; Tabagari DZ
    Sov Med; 1989; (10):39-41. PubMed ID: 2617340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of passive lymphocyte transfer on the course of autoimmune thyroiditis in guinea pigs].
    Artemova EP; Sirota AR
    Probl Endokrinol (Mosk); 1993; 39(4):52-4. PubMed ID: 8415534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunocorrective therapy of autoimmune and subacute thyroiditis].
    Balabolkin MI; Arion VIa; Sakaeva NA
    Sov Med; 1989; (6):106-8. PubMed ID: 2799479
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of plasmapheresis and immunocorrective therapy on the status of the T-cell component of immunity in patients with autoimmune thyroiditis].
    Kalinin AP; Rafibekov DS; Potemkina EE; Shabadin VN
    Probl Endokrinol (Mosk); 1994; 40(4):21-3. PubMed ID: 7971902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ultrastructure of the blood lymphoid cells and the dynamics of cellular immunity indices in chronic lympholeukemia patients during immunocorrection with T-activin].
    Chuvirov GN; Markova TP
    Ter Arkh; 1986; 58(9):67-70. PubMed ID: 3787495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical effectiveness of thymus preparations (T-activin, thymalin) in erysipelas infection].
    Frolov VM; Peresadin NA; Pustovoĭ IuG; Gaĭdash IS; Tishchenko NA; Gavrilova LA; Pinskiĭ LL
    Sov Med; 1990; (6):111-3. PubMed ID: 2144365
    [No Abstract]   [Full Text] [Related]  

  • 8. [Principles of immunocorrective therapy using the thymus preparation T-activin].
    Arion VIa; Ivanushkin EF
    Khirurgiia (Mosk); 1984 Nov; (11):44-8. PubMed ID: 6335205
    [No Abstract]   [Full Text] [Related]  

  • 9. [The immunological criteria in the expediency of prescribing T-activin to patients with primary pulmonary tuberculosis].
    Sakhelashvili-Haladzhun MI
    Lik Sprava; 1994; (9-12):103-5. PubMed ID: 7604543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinico-immunological effects of T-activin in the combined treatment of patients with acute suppurative pyelonephritis].
    Vozianov AF; Drannik GN; Pasechnikov SP; Driianskaia VE; Petrovskaia IA; Kushko LIa; Ozvinchuk II; Potrebinskiĭ VM; Milinevskiĭ VA
    Lik Sprava; 1995; (9-12):81-3. PubMed ID: 8983802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of T-activin in the intensive therapy of the postoperative period in gestosis patients].
    Ianiushina VV
    Anesteziol Reanimatol; 1992; (4):42-5. PubMed ID: 1485674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive transfer of experimental autoimmune thyroiditis (EAT) in guinea pigs: requirement for Ia-positive antigen-presenting cells for in vitro activation of effector T cells.
    Braley-Mullen H; Tompson JG; Sharp GC; Kyriakos M
    Cell Immunol; 1983 Oct; 81(2):243-52. PubMed ID: 6605804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical effectiveness of T-activin in the treatment of cutaneous forms of lupus erythematosus].
    Skripkin IuK; Biriukov AV; Stenina MA; Skripnik AIu; Korotkiĭ NG
    Vestn Dermatol Venerol; 1985 May; (5):8-11. PubMed ID: 3898631
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy of treating patients with disseminated forms of destructive pulmonary tuberculosis using chemical preparations and T-activin].
    Chukanov VI; Gergert VIa; Khomenko IS
    Probl Tuberk; 1989; (6):30-3. PubMed ID: 2771908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of immunological indices for assessing the severity of the course of periodontitis and treatment efficacy].
    Bazhanov NN; Ter-Asaturov GP; Kassin VIu; Ivaniushko TP; Arion VIa; Simonova AV
    Stomatologiia (Mosk); 1996; 75(1):15-8. PubMed ID: 8658566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The validation of the use of thymic preparations in tuberculous infection by experimental data].
    Demidov SV; Miasnikov VG; Chernushenko EF; Osipova LS
    Vrach Delo; 1991 May; (5):53-5. PubMed ID: 1866916
    [No Abstract]   [Full Text] [Related]  

  • 17. [Secondary autoimmune syndrome and immunomodulating lymphotropic therapy in acute pancreatitis].
    Zaĭrat'iants OV; Kolobov SV; Iarema IV; Shevchenko VP
    Arkh Patol; 2002; 64(6):51-6. PubMed ID: 12534231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro tests for cell-mediated immunity in thyroid disease.
    Calder EA
    Proc R Soc Med; 1974 Jun; 67(6 Pt 1):502-6. PubMed ID: 4546830
    [No Abstract]   [Full Text] [Related]  

  • 19. [T-activin in multimodal treatment of systemic lupus erythematosus in children].
    Kartasheva VI; Tarasova LR; Zaĭrat'iants OV; Belokrinitskiĭ DV
    Pediatriia; 1991; (3):47-52. PubMed ID: 2047179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of a monoclonal antibody to interferon-gamma on experimental autoimmune thyroiditis (EAT): prevention of disease and decrease of EAT-specific T cells.
    Tang H; Mignon-Godefroy K; Meroni PL; Garotta G; Charreire J; Nicoletti F
    Eur J Immunol; 1993 Jan; 23(1):275-8. PubMed ID: 8419180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.